Page last updated: 2024-11-06

mitomycin and Multiple Sclerosis, Relapsing-Remitting

mitomycin has been researched along with Multiple Sclerosis, Relapsing-Remitting in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Multiple Sclerosis, Relapsing-Remitting: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kleist, C1
Mohr, E1
Gaikwad, S1
Dittmar, L1
Kuerten, S1
Platten, M1
Mier, W1
Schmitt, M1
Opelz, G1
Terness, P1

Other Studies

1 other study available for mitomycin and Multiple Sclerosis, Relapsing-Remitting

ArticleYear
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
    Journal of translational medicine, 2016, 05-01, Volume: 14, Issue:1

    Topics: Animals; Apoptosis; Autoantigens; Cell Movement; Disease Models, Animal; Encephalomyelitis, Autoimmu

2016